AnalystsJonathan MillerJonathan Miller's Stock Forecasts
AnalystsJonathan Miller
Sectors:
Industries:
Analyst Ranking
Bottom 11%
#4619 out of 5147 analysts
Average Return
-32.03%
Win Rate
29%2 out of 7
Risk vs Reward
Poor
Good
Jonathan Miller's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gamida Cell LtdGMDAQ | +41.85% | $4.54 | $6.44 | 2020-06-30 - 2021-07-01 | Buy |
Aura Biosciences IncAURA | +2.04% | $6.38 | $6.51 | 2025-11-25 - 2025-12-11 | Buy |
Jonathan Miller Analyst Color
Get additional color on Jonathan Miller's coverage of popular stocks
Jonathan Miller's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aura Biosciences IncAURA | 1 | Buy | $13.00 | +99.69% | Reinstates | 16 days ago |
Intellia Therapeutics IncNTLA | 1 | Hold | $8.00 | -16.23% | Downgrades | a month ago |
Prokidney CorpPROK | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Vaxxinity IncVAXX | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Entrada Therapeutics IncTRDA | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Shattuck Labs IncSTTK | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Sqz Biotechnologies CoSQZB | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Nanobiotix SaNBTX | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.